1. Conference Secretariat
2360 Corporate Circle, Suite 400, Henderson, NV 89074-7722, USA
Tel: +1-888-843-8169, Fax: +1-650-618-1417
Email: europersonalizedmedicine@conferenceseries.net
Brochure
europersonalizedmedicine@conferenceseries.neteurope/
Emphasizing the
Knowledge of Personalized Medicine
Valencia, Spain
July 21-22, 2016 EUROPE
4th
European Conference on
Genomics and Personalized Medicine
2. OMICS International welcomes you to attend the 4th
International
Conference on Genomic & Personalized Medicine Scheduled during
July 21-22, 2016 at Valencia, Spain.
We are expecting your valuable participation at Euro
Personalized Medicine 2016 highlighting the theme
“Emphasizing the Knowledge of Personalized Medicine”
along with the scientific program which paves a way to gather
visionaries through the research talks and presentations. The
ultimate mission of the conference is to put forward many
thought provoking the Novel Approaches and Innovations in
personalised medicine and healthcare, serves an impulse for
the advancement of Molecular Diagnostics, a brief discussion
on Protein Biomarkers, special focus on Genetics Informed
Personalized Immunotherapy and Stem Cells Therapy as the Future
of Personalised Medicine. Personalized Medicine promises many
medical innovations, and has the potential to change the way treatments are
discovered and used.
Euro Personalized Medicine 2016 is a remarkable event which brings together a unique and
international mix of Participants from Universities, Institutes, Research and Pharma companies.
Come, let’s join together to Emphasize the Knowledge of Personalized Medicine
Regards,
Euro Personalized Medicine 2016 Operating Committee
Invitation
europersonalizedmedicine@conferenceseries.net
3. OMICS International Journals
• 500 Open Access Journals
• 21 Day rapid review process
• 50000 Editorial team, 30000 Reviewers team
• 3.5 Million readers and high visibility
• More than 100000
• Publication immediately after acceptance
• Quality and quick editorial, review processing
Key features
• User friendly/feasible website translation of your
paper to 50 world’s leading languages
• Enhanced feature: Audio version of published paper
• Digital articles to share and explore
• Sharing option: Social networking enabled
• Authors, reviewers and editors are provided with
scientific credits
OMICS International Conferences
• 300+ Conferences all over the World every year
• Well organized scientific program
• Renowned speakers and scientists across the globe
• Poster presentations and world class exhibits
• Panel discussions and interactive sessions
• B2B meetings
• Perfect platform for Global Networking
Key features
• Presentation by renowned speakers from all over the
world
• Poster presentations and world class exhibits
• Interactive Sessions
• Platform for global networking
• Connecting scientific community
Special Issues
All accepted abstracts will be published in respective OMICS Group Journals
Each abstract will be provided with digital Object Identifier by
About us
europersonalizedmedicine@conferenceseries.net
4. Personalized medicine therapeutics and Molecular diagnostic have huge opportunities for growth in
healthcare and will improve therapeutic effectiveness and reduce the severity of adverse effects approach
to drug therapies. The significance can be gauged by the fact that it has made huge advancements over the
course of time and is continuing to influence various sectors.
Euro Personalized Medicine 2016
• Opportunity to attend the presentations delivered by eminent scientists from all over the world
• Selected contributions will be published in following OMICS International Journals
• Journal of Pharmacogenomics & Pharmacoproteomics
• Journal of Molecular and Genetic Medicine
• Journal of Nanomedicine & Nanotechnology
• Translational Medicine
• Journal of Clinical Case Reports
• Participation in sessions on specific topics on which the conference is expected to achieve progress
• Global networking: In transferring and exchanging Ideas
• Conference brings together Scientific Researchers, Medical Surgeons and Physicians
Conference highlights:
• Personalized Medicine and its Innovations
• Market Strategies and Challenges in Personalised
Medicine
• Pharmacogenomics: Convergence of Pharmacology and
Genomics
• Genomics and Personalized Medicine
• Genetics of Ebola Outbreak
• Approaches to Stem Cells
• Nanotechnology: Future of Personalised Medicine
• Personalised Medicine in 21st Century
• Personalized Drug Therapy
• Advances in Molecular Diagnostics
• Paths of Biomarkers
• Clinical Case Reports
• Lifestyle Medicine
• Preventive Medicines
Highlights
europersonalizedmedicine@conferenceseries.net
5. europersonalizedmedicine@conferenceseries.net
With the motto to “Accelerate Scientific Research” –Conferenceseries LLC has succeeded immensely in bringing
together the big brains, industrial giants, renowned speakers and scientists providing them with the platform to
collaborate and build research partnership. It’s no exaggeration that we got an opportunity to work with the big
names since last three years in the field of personalized Medicine and Molecular Diagnostics such as….
2015
Vincent Gallicchio, Clemson University, USA
Ananda Prasad, Wayne State University, USA
Anatoly V Skalny, Trace Element Institute for UNESCO, France
Constantin Polychronakos, McGill University, Canada
Jang-Ung, School of Material Science and Engineering, South
Korea
Adrián Llerena, RIBEF Ibero-Latinoamerican Network of
Pharmacogenetics, Spain
Cecilia Gelfi, University of Milano, Italy
Iris Lavon, Hadassah Hebrew University, Israel
Sangeeta Shukla, Vice Chancellor Jiwaji University, India
Kenney-Herbert Emma, Cambridge University, UK
Mohamed Abdulla, Primary care center, Sweden
Sangeeta Shukla, Jiwaji University, India
Maria Angeles Pajares, Instituto de Investigaciones Biomédicas
Alberto Sols (CSIC-UAM), Spain
David Cheng, Sidra Medical and Research Center, Qatar
Sadhana Shrivastava, Jiwaji University, India
Jean Gabert, Hopitaux de Marseille, France
Manuel Perez Alonso, University of Valencia Science Park, Spain
Lars Von Olleschik-Elbheim, ACON Laboratories, Germany
Guilherme Martins Santos, University of Brasilia, Brasilia
Lars Von Olleschik-Elbheim, ACON Laboratories, Germany
Reda Mohamed Elbadawy, Banha University Faculty of Medicine,
Egypt
Guo-Hui Fu, Shanghai Jiao Tong University, China
Maysa Kamal Salama, Cairo University, Egypt
Yin Hua Zhang, Seoul National University, South Korea
Fika Atroshi, Rinnekoti Research Center, Finland
2014
Vincent Gallicchio, Clemson University, USA
Sergey Suchkov, I M Sechenov First Moscow State Medical
University, Russia
Mukesh Verma, National Cancer Institute, USA
Claudio Nicolini, University of Genova, Italy
Catherine Brownstein, Boston Children’s Hospital, USA
David Cheng, Sidra Medical and Research Center, Qatar
Julia Matena, University of Veterinary Medicine, Germany
Tao Wu, Shanghai University of Traditional Chinese Medicine,
China
Alice Zemljic-Harpf, University of California, USA
Jing-bin Huang, Guangxi University of Chinese Medicine, China
Emil Alexov, Clemson University, USA
Hsiu-Ni Kung, National Taiwan University, Taiwan
Cristina Patassini, Genetyx S.R.L., Italy
Guillermo Barreto, Max Planck Institute for Heart and Lung
Research, Germany
Mark D Gorrell, University of Sydney, Australia
Tereza Jancuskova, CHAMBON, Czech Republic
Evgeniya Peshkova, University of Genova, Italy
Afaf El-Ansary, King Saud University, Saudi Arabia
Abeer Kadry El Zohiery, Ain Shams University, Egypt
Emmanuel C Besa, Thomas Jefferson University, USA
Ananda S Prasad, Wayne State University School of Medicine,
USA
Frank S Ong, Illumina Inc., USA
Anton Yuryev, Elsevie, USA
Luminita Castillos, Personalized Hematology-Oncology of Wake
Forest, USA
Jessica Foley, Helen DeVos Children’s Hospital, USA
Alireza Hadj Khodabakhshi, Genomic Institute of Novartis
Research Foundation, USA
Kelvin K Tsai, National Institute of Cancer Research, Taiwan
Caroline Diorio, Laval University, Canada
Sevtap Savas, Memorial University of Newfoundland, Canada
Tahany H Ayaad, King Saud University, Saudi Arabia
Wei Xu, University of Toronto, Canada
Amir Y Shaik, University of Massachusetts Medical School,
University of Massachusetts Medical School
Pranay Tanwar, All India Medical Institute, India
Guo-HuiFu, Shanghai Jiao Tong University School of Medicine,
China
Zohreh Mahmoodi, Alborz university of medical sciences, Iran
Abdel Kareem Azab, Washington University in Saint Louis School
of Medicine, USA
Sergey Suchkov, EPMA Member Moscow State Medical University,
Russia
Trevor G Marshall, Autoimmunity Research Foundation, usa
Kirill Shlyapnikov, M Sechenov First Moscow State Medical
University, Russia
Afaf El-Ansary, King Saud University, Saudi Arabia
Saleem Meerani, Steward Carney Hospital, usa
2013
Maurizio Chiriva Internati, Texas Tech University, USA
Michael Retsky, Harvard School of Public Health, USA
Vincent Gallicchio, UNESCO, USA
Toshihisa Ishikawa, RIKEN Omics Science Center, Japan
Hans Peter Zenner, University of Tuebingen, Germany
Alireza Haghighi, Harvard Medical School, USA
Jennifer Rooke, Medical Director of Advanced Lifestyle Medicine,
USA
Alasdair MacKenzie, University of Aberdeen, UK
Takuya Iwamoto, Mie University, Japan
Noriko Sato, Tokyo Medical & Dental University, Japan
Ann-Marie Chacko, University of Pennsylvania, USA
6. Nan Hu, University of Utah, USA
Enty Tjoa, University of Indonesia, Indonesia
Rong Chen, University of Maryland, USA
Subramani Mani, University of New Mexico, USA
Fayyad-Kazan Hussein, Universite Libre de Bruxelles, Belgium
Hiba A. Awooda, Al Neelain University, Sudan
evtap Savas, Memorial University of Newfoundland, Canada
Chanderdeep Tandon, Jaypee University of Information
Technology, India
Margarita Irizarry-Ramirez, University of Puerto Rico, Puerto Rico
Xiaojiang Cui, Cedars-Sinai Medical Center, USA
Jamboor K.Vishwanatha, UNT Health Science Center, USA
Jingfang Ju, Stony Brook University, USA
Yong-Chao Ma, Northwestern University, USA
Antonio Gomez Munoz, University of the Basque Country, Spain
Dik C. Van Gent, Erasmus MC, Netherlands
Gerson Chadi, University of Sao Paulo, Brazil
B. J. Nickoloff, Michigan State University, USA
Fabio Grizzi, Humanitas Clinical and Research, Italy
Michael Danquah, Chicago State University, USA
Qinwen Mao, Northwestern University Feinberg School of
Medicine, USA
Ilia Fishbein, University of Pennsylvania, USA
Thomas Fritsch, The Wisconsin Parkinson Association, USA
immanuel Freedman, GlaxoSmithKline, USA
Uri Herzberg, Celgene Cellular Therapeutics, USA
Dan Housman, Recombinant By Deloitte, USA
Betty Tyler, Johns Hopkins University School of Medicine, USA
Jackie Wypij, University of Illinois, USA
Ganga Chandramohan, University of California, USA
Kazuhiro Aoki, Tokyo Medical and Dental University, Japan
Yoshihiro Hataguchi, Ako Kasei co.ltd, Japan
Anil S. Modak, Cambridge Isotope Laboratories Inc., USA
Mark Gorrell, University of Sydney, Australia
Halaris Angelos, Loyola University Medical Center, USA
Dik C. Van Gent, Erasmus MC, Netherlands
Vladimir A. Kuznetsov, Bioinformatics Institute, Singapore
Sin Lee, Chinese Academy of Sciences, China
Farooq A. Shiekh, Avalon University school of Medicine,
Netherlands
Rajesh D Patel, Genentech, USA
Douglas K. Price, National Cancer Institute, USA
Rihova Blanka, Academy of Sciences of the Czech Republic,
Czech Republic
Jian-guo Sun, Third Military Medical University, China
Hua Fang, University of Chicago, USA
Oladipo Aina, Ahmadu Bello University, Nigeria
Paul A. Frohna, ProFibrix Inc. & Frohna Biotech Consulting, USA
Ena Ray Banerjee, University of Calcutta, India
Wanda Sicinska, University of Warsaw, Poland
Shu-Feng Zhou, University of South Florida, USA
Thomas L. Lenz, Creighton University, USA
Richard A. Montagna, Rheonix Inc., USA
Madhup Chaurasia, Lincolnshire Clinical Trials Unit, uk
Jean Gabert, University Hospital, France
David L. Dolinger, Seegene Inc., Republic of Korea
Toshihisa Ishikawa, RIKEN Omics Science Center, Japan
William R. Ware, University of Western Ontario, Canada
Philip Onuoha, University of the West Indies, Trinidad and
Tobago
For research titles and presentations of above mentioned speakers and delegates visit conference home
page and look for the proceedings in the footer. europersonalizedmedicine@conferenceseries.net
2015
Proceedings
2014 2013
7. Valencia is the third largest city of Spain with a global city status. Valencia was the 29th fastest
improving European city. Its influence in commerce, education, entertainment, media, fashion,
science and the arts contributes to its status as one of the world’s “Gamma”-rank global cities.
The port city of Valencia is on Spain’s southeastern Orange Blossom Coast, where the Turia
River meets the Mediterranean Sea. It’s known for its City of Arts and Sciences, with futuristic
structures including a planetarium, an oceanarium and an interactive museum. Valencia also
has several beaches, including some within nearby Albufera Park, a wetlands reserve with a lake,
walking trails and bird-watching.
Valencia is a place where medical institutions, hospitals and clinical research organizations
are situated. Therefore it would be a very great place which supports the conference and helps in
advancing clinical knowledge and treatment therapy.
About Valencia
europersonalizedmedicine@conferenceseries.net
8. Mail us to know more!
For Abstract Submission Guidelines | For Reserving your slot | Proposals | Registration | Posters | Accommodations
No doubt you have lots of queries...
Why not get in touch..!
Drop us your query with details and we will call you right away
For Exhibition & Sponsorship queries
Contact: Max Steven
Email: personalizedmedicine@conferenceseries.net
Direct Line: +1-702-508-5200 Extn: 8036
Hosted by OMICS International
2360 Corporate Circle, Suite 400,
Henderson, NV 89074-7722, USA
Tel: +1-888-843-8169, Fax: +1-650-618-1417
europersonalizedmedicine@conferenceseries.net
Contact Us
Venue:
Valencia, Spain
Important Dates
Abstract submission opens: October 10, 2015
Registration opens: October 15, 2015
Early Bird Registration: February 22, 2016
Registration: April 25, 2016
Final Registration Date: July 21, 2016